Japan's Health Ministry Approves 197 Generics For NHI Listing, Including 22 Generic Versions Of Pfizer's Xalatan Eye Drops
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japan's Ministry of Health Labor and Welfare May 28 released for National Health Insurance coverage listing a total of 197 generic drugs, down sharply from the 318 items listed in May 2009; the decline seems to contradict the Japanese government's policy goal of raising the proportion of generics to 30 percent by the end of March 2013 from 17.6 percent in March 2009
You may also be interested in...
Japan Adds 12 Drugs To NHI Price List; Takeda Takes Four, Pfizer, Alexion Also Gain
Japan's Central Social Medical Insurance Agency (Chuikyo) June 2 approved the addition of 29 products of 12 ingredients. Among them, six are new chemical entities, four are new combinations and two are new administration routes with one additional indication and dosage
Japan Adds 12 Drugs To NHI Price List; Takeda Takes Four, Pfizer, Alexion Also Gain
Japan's Central Social Medical Insurance Agency (Chuikyo) June 2 approved the addition of 29 products of 12 ingredients. Among them, six are new chemical entities, four are new combinations and two are new administration routes with one additional indication and dosage
Massive U.S. Government Delegation Seeks Common Ground In China To Counter Threats To Peace And Health
BEIJING - One of the most extensive American government delegations to make a state visit to China - headed by Secretary of State Hillary Clinton and Treasury Secretary Tim Geithner - posted only sporadic progress this week across a spectrum of issues affecting ties between the globe's financially hobbled superpower and fastest rising economic force, yet the two sides renewed an important pact on jointly tracking and fighting infectious diseases that have the potential to crisscross the continents